HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Host-derived antibody-dependent cytotoxic cells within murine tumors.

Abstract
Mouse ascites tumor preparations had strong antibody-dependent cell-mediated cytotoxic (ADCC) activity, whereas cultured tumor cells did not. L5178 lymphoma cells reversibly expressed surface Fc receptors in vivo but not in vitro. Cultured lymphoma cells grown in vivo in diffusion chambers expressed Fc receptors but not ADCC activity. These results suggest that an Fc receptor is not sufficient to endow a cell with ADCC activity. The transplanted ascites tumors L5178 and MOT, an ovarian teratoma, contained about 2-5% host-derived cells, which represents a significant increase in the total number of host-derived peritoneal cells compared to the number of cells found in nontumor-bearing mice. These infiltrating host cells were separated from the ascites tumor cells by velocity sedimentation and by lysis with antibody and complement. In both instances, all the ADCC activity was associated with the host cells, whereas cells, such as killer cells and macrophage;, infiltrate ascites tumors and completely account for the potent ADCC activity associated with ascites tumor preparations.
AuthorsD E Tracey, S L Silberman
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 64 Issue 1 Pg. 111-8 (Jan 1980) ISSN: 0027-8874 [Print] United States
PMID6928035 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Receptors, Fc
Topics
  • Animals
  • Antibody-Dependent Cell Cytotoxicity
  • Ascites (immunology)
  • Cell Separation
  • Cells, Cultured
  • Female
  • Leukemia L5178 (immunology)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Neoplasms, Experimental (immunology, pathology)
  • Ovarian Neoplasms (immunology)
  • Receptors, Fc
  • Teratoma (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: